The compound dapoxetine will be marketed as Priligy for premature ejaculation
Here’s a description of J&J’s clinical development of the drug:
The drug extends intercourse time from a humbling two minutes to a still fairly humbling seven minutes, per a J&J-sponsored study. In that study, J&J claims, “wives and girlfriends timed intercourse with a stopwatch over a 12-week period.” The company believes PE affects “27-34% of men across all age ranges.”
J&J has tried hard to get dapoxetine to market. The company started doing PR for the drug back in 2005. At the time, Merrill Lynch analyst Katherine Martinelli bought the hype, hailing the drug as “the new Viagra” in The New York Sun.
The drug, a repurposed short-acting antidepressant, was rejected by the FDA a couple of years ago, around the same time as concerns over antidepressant effectiveness and suicidal-thought side effects became a concern in the category.